NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Long Term Provisions | ₹85 Cr | ₹96 Cr | ₹100 Cr | ₹90 Cr | ₹71 Cr |
What is the latest Long Term Provisions ratio of NATCO PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2023 | ₹85 Cr |
Mar2022 | ₹96 Cr |
Mar2021 | ₹100 Cr |
Mar2020 | ₹90 Cr |
Mar2019 | ₹71 Cr |
How is Long Term Provisions of NATCO PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2023 | ₹85 Cr | -10.87 | |
Mar2022 | ₹96 Cr | -3.92 | |
Mar2021 | ₹100 Cr | 10.42 | |
Mar2020 | ₹90 Cr | 27.04 | |
Mar2019 | ₹71 Cr | - |
Compare Long Term Provisions of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹18,107.0 Cr | 1.9% | 4.7% | 78.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 1.9% |
4.7% |
78.2% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses